Frontiers | HGF/c-Met Axis: The Advanced Development in Digestive System Cancer
Frontiers | Selective Inhibitor of the c-Met Receptor Tyrosine Kinase in Advanced Hepatocellular Carcinoma: No Beneficial Effect With the Use of Tivantinib?
Artificial human Met agonists based on macrocycle scaffolds | Nature Communications